Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Meta-Anal. Feb 28, 2021; 9(1): 1-11
Published online Feb 28, 2021. doi: 10.13105/wjma.v9.i1.1
Published online Feb 28, 2021. doi: 10.13105/wjma.v9.i1.1
Inflammatory pseudotumor-like follicular dendritic cell sarcoma: Literature review of 67 cases
Hao Wu, Peng Liu, Xiao-Ran Xie, Jing-Shu Chi, Huan Li, Can-Xia Xu, Department of Gastroenterology, Third Xiangya Hospital of Central South University, Changsha 410013, Hunan Province, China
Author contributions: Wu H and Liu P conceived and designed the study; Wu H wrote the paper; Xie XR contributed to data acquisition; Chi JS and Li H analyzed the data; Xu CX contributed to the revisions; All authors read and approved the manuscript.
Supported by National Natural Science Foundation of China , No. 81570509 .
Conflict-of-interest statement: The authors declare having no conflict-of-interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Can-Xia Xu, MD, PhD, Professor, Department of Gastroenterology, Third Xiangya Hospital of Central South University, No. 138 Tongzipo Road, Changsha 410013, Hunan Province, China. xucanxia2000@163.com
Received: December 23, 2020
Peer-review started: December 23, 2020
First decision: December 30, 2020
Revised: January 2, 2021
Accepted: February 25, 2021
Article in press: February 25, 2021
Published online: February 28, 2021
Processing time: 68 Days and 12.9 Hours
Peer-review started: December 23, 2020
First decision: December 30, 2020
Revised: January 2, 2021
Accepted: February 25, 2021
Article in press: February 25, 2021
Published online: February 28, 2021
Processing time: 68 Days and 12.9 Hours
Core Tip
Core Tip: We show that inflammatory pseudotumor-like follicular dendritic cell (FDC) sarcoma appears to be mildly aggressive and does require annual surveillance. Surgery is the most effective treatment modality, and the role of adjuvant chemotherapy for postoperative management is unclear. Epstein-Barr virus is likely to play an important role in the etiology of inflammatory pseudotumor-like FDC sarcoma.